Clinical phase Ib patient enrollment completed

Enrollment completed in the phase Ib study of genistein-SSDH for the treatment of pancreatic cancer. All sixteen patients with locally advanced or metastatic pancreatic cancer has been enrolled and treated with genistein-SSDH in combination with gemcitabine.